ARTICLE | Management Tracks
Plus: Evan Ballantyne named CFO at Hansa and updates from BostonGene and InflaRx
By Gunjan Ohri, Data Content Analyst
February 24, 2024 1:24 AM UTC
Astellas Pharma Inc. (Tokyo:4503) hired Michael Petroutsas as head of U.S. commercial at its Astellas Pharma US Inc. unit. Petroutsas was SVP, U.S. specialty and oncology business at GSK plc (LSE:GSK; NYSE:GSK). He succeeds Mark Reisenauer, who is leaving at the end of March.
Evan Ballantyne will become CFO of Hansa Biopharma AB (SSE:HNSA) on March 1, succeeding Donato Spota. Ballantyne was SVP, CFO at Gain Therapeutics Inc. (NASDAQ:GANX)…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/651520/petroutsas-to-lead-u-s-commercial-operations-at-astellas